220 related articles for article (PubMed ID: 15761791)
1. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
Bode-Böger SM
Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
Nakai Y; Voisine P; Bianchi C; Xu SH; Feng J; Malik T; Rosinberg A; Sellke FW
Surgery; 2005 Aug; 138(2):291-8. PubMed ID: 16153439
[TBL] [Abstract][Full Text] [Related]
3. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio.
Bode-Böger SM; Scalera F; Ignarro LJ
Pharmacol Ther; 2007 Jun; 114(3):295-306. PubMed ID: 17482266
[TBL] [Abstract][Full Text] [Related]
4. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
Tousoulis D; Böger RH; Antoniades C; Siasos G; Stefanadi E; Stefanadis C
Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):274-83. PubMed ID: 17457351
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
[TBL] [Abstract][Full Text] [Related]
7. [Arginine and statins: relationship between the nitric oxide pathway and the atherosclerosis development].
Rasmusen C; Cynober L; Couderc R
Ann Biol Clin (Paris); 2005; 63(5):443-55. PubMed ID: 16230278
[TBL] [Abstract][Full Text] [Related]
8. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
Böger RH
Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
[TBL] [Abstract][Full Text] [Related]
9. The clinical pharmacology of L-arginine.
Böger RH; Bode-Böger SM
Annu Rev Pharmacol Toxicol; 2001; 41():79-99. PubMed ID: 11264451
[TBL] [Abstract][Full Text] [Related]
10. Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection?
Brunini TM; Mendes-Ribeiro AC; Ellory JC; Mann GE
Cardiovasc Res; 2007 Jan; 73(2):359-67. PubMed ID: 17078937
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and vascular insulin resistance.
Wu G; Meininger CJ
Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
[TBL] [Abstract][Full Text] [Related]
12. [New possibilities in treatment of atherosclerosis--increase of nitric oxide synthesis by L-arginine supplementation].
Kielar M; Myrcha P; Pleban E
Pol Merkur Lekarski; 2004 Dec; 17(102):656-60. PubMed ID: 15771145
[TBL] [Abstract][Full Text] [Related]
13. L-arginine--substrate for no synthesis--its beneficial effects in therapy of patients with peripheral arterial disease: comparison with placebo-preliminary results.
Slawinski M; Grodzinska L; Kostka-Trabka E; Bieron K; Goszcz A; Gryglewski RJ
Acta Physiol Hung; 1996; 84(4):457-8. PubMed ID: 9328630
[TBL] [Abstract][Full Text] [Related]
14. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
15. Vascular effects of dietary L-arginine supplementation.
Preli RB; Klein KP; Herrington DM
Atherosclerosis; 2002 May; 162(1):1-15. PubMed ID: 11947892
[TBL] [Abstract][Full Text] [Related]
16. Amino acids, arginase and nitric oxide in vascular health.
Huynh NN; Chin-Dusting J
Clin Exp Pharmacol Physiol; 2006; 33(1-2):1-8. PubMed ID: 16445692
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
18. Dietary L-arginine in renal disease.
Peters H; Noble NA
Semin Nephrol; 1996 Nov; 16(6):567-75. PubMed ID: 9125801
[TBL] [Abstract][Full Text] [Related]
19. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test.
Jesse CR; Bortolatto CF; Savegnago L; Rocha JB; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1838-43. PubMed ID: 18773934
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile.
Gerth K; Ehring T; Braendle M; Schelling P
Clin Toxicol (Phila); 2006; 44 Suppl 1():29-36. PubMed ID: 16990191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
